Pune, India, March, 2019/MRFR Press Release/- Market Research Future has published a half-cooked research report on the Global Skin Biopsy Market.
The global skin biopsy market is expected to exhibit a CAGR of 9.4% over the forecast period from 2017 to 2023, according to a new report from Market Research Future (MRFR). The global skin biopsy market is analyzed in detail in the report, which takes a look at the historical growth trajectory of the global skin biopsy market to point out key indicators of the market’s movement. Using these indicators, the report presents a detailed landscape of the skin biopsy market’s potential growth trajectory over the forecast period. The report also compiles an extended analysis on the market’s key drivers as well as the key restraints likely to hold back the market over the forecast period.
The global skin biopsy market is mainly driven by the growing prevalence of skin cancer and the utilization of skin biopsy in skin cancer diagnosis. Like in any other type of cancer, biopsy plays a key role in diagnosing skin cancer and is widely used for the same. Skin biopsy provides physicians with a hands-on view of the disease site and allows them to diagnose the condition without being bothered by variables such as the patient’s location and without worrying about the patient’s discomfort. The growing awareness about skin cancer in emerging regions is likely to be a major driver for the global skin biopsy market, as it has become increasingly easier to diagnose and treat skin cancer in developing regions in the last few years with the growing availability of advanced medical facilities.
The growing prevalence of other skin disorders and infections is also likely to be a major driver for the global skin biopsy market. Skin biopsy also serves to diagnose other skin conditions such as psoriasis, dermatitis, and other pathogenic and environmental infections. The growing air pollution, which puts a strain on skin health and makes it likelier that some infections will penetrate the skin, is likely to drive the demand from the skin biopsy market over the forecast period.
The global skin biopsy market is segmented on the basis of type, device, indication, end user, and region.
On the basis of type, the global skin biopsy market is segmented into shave biopsy, punch biopsy, excisional biopsy, and incisional biopsy.
On the basis of devices, the skin biopsy market is segmented into needle-based biopsy guns, biopsy curettes and punches, guidance systems, biopsy forceps, biopsy needles, and others.
On the basis of indication, the skin biopsy market is segmented into actinic keratosis, dermatitis, psoriasis, skin infection, cancer, and others. The skin infection segment is further segmented into viral infections, deep fungal infections, basal cell carcinoma, squamous cell carcinoma, and melanoma.
On the basis of end user, the market is segmented into hospitals, dermatology clinics, and others.
Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/skin-biopsy-market-4650
The global skin biopsy market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas dominates the global skin biopsy market on the back of the growing prevalence of skin cancer in the region, the growing availability of advanced anti-cancer medication and procedures, and the growing prevalence of skin diseases. According to the American Academy of Dermatology, one in four American is affected by skin disease of some kind. This is likely to drive the demand for skin biopsies at a rapid rate over the forecast period.
Europe holds the second largest share in the global skin biopsy market and is likely to remain a leading contributor over the forecast period due to the growing prevalence and awareness about skin cancer in the region. The easy availability of advanced diagnosis protocols in Europe is also likely to be a major driver for the Europe market for skin biopsy over the forecast period.
Asia Pacific is likely to be increasingly important for the global skin biopsy market over the forecast period due to the growing awareness about skin diseases, including skin cancer.
Leading players in the global skin biopsy market include Boston Scientific Corporation, BD, Devicor Medical Products Inc., Hologic Inc., Cardinal Health, Gallini Srl, DTR Medical Ltd., and Cook Medical.
In March 2019, researchers found a way to detect prions indicating the presence of mad cow disease through a skin biopsy. This method offers much faster diagnosis of mad cow disease than conventional methods.